Children rarely suffer from the condition which Hamman and Rich (1944) called 'acute' diffuse interstitial fibrosis of the lungs. Later reports of this condition detail a chronic process more appropriately described by terms like 'chronic diffuse fibrosis of the lungs', 'interstitial pneumonitis', and 'idiopathic pulmonary fibrosis'. Scadding (1964) proposed the term 'fibrosing alveolitis' to describe those progressive lung diseases characterized by varying combinations of two histological features: thickening of alveolar walls and the presence of large mononuclear cells in the alveolar spaces.
Liebow et al. (1965) observed intra-alveolar desquamation of large mononuclear cells in the lungs of patients suffering from a progressive lung disease and called the condition 'desquamative interstitial pneumonia' (DIP). It was implied that this group was different in pathogenesis from 'other forms of interstitial pneumonia', but Scadding and Hinson (1967) felt that the histological evidence for this to that of the other children and a younger sib, also English. The clinical details of Case 2 have already included, died aged 6 months when the lungs showed been reported (Liebeschuetz and Butler, 1965) . the characteristic pathology. In order to consolidate information on this rare disease, the clinical features Patients of these 10 children are reported and they have been compared with those of 31 children with this con-Brief clinical details of the 10 patients are given in dition previously reported in published reports in Table 1 . The disease led to a number of life-threatening complications (Table 3) . Superimposed bacterial infections, as judged by fever, isolation of pathogen, and response to antibiotic therapy, were unusual. Respiratory failure was considered to be present if the Pao2 was <60 torr with the patient breathing air. Persistent central cyanosis in children in whom blood gas analysis was not made was taken as evidence of respiratory failure. It occurred in 9 out of 10 children in the early stages of the disease and was quickly fatal in one (Case 10) who also developed bilateral pneumothoraces. Pneumothorax also occurred.
Cardiac failure in a patient with chronic respiratory disease is frequently difficult to assess. Tachypnoea, tachycardia, and fluid retention are common to both and the jugular venous pulse is a difficult sign in small children. Therefore, two criteria were used to decide whether heart failure was present, an enlarging heart shown by chest x-ray and an increasing liver size. With this difficulty in mind, the use of digoxin has been recorded in a separate column. The complications in these 10 patients reflected their incidence in published reports. The immediate cause of death was cardiac failure with hypertension in one, and cardiorespiratory failure in the others.
Radiology. Chest x-rays were graded in severity from 0 to + + + for the following features: groundglass appearance, fine mottling (<2 mm), coarse mottling (> 2 mm), linear markings, and hyperlucent areas. Areas of collapse and consolidation were noted together with the presence of other features such as pneumothorax, effusions, and heart size. The radiological features were then correlated to the clinical course and corticosteroid therapy.
Early in the course of the disorder the chest x-ray usually showed a diffuse, bilateral ground-glass appearance with fine mottling. In those patients who survived, the chest x-ray showed a surprisingly consistent sequence of changes (Fig. 1) . The early features of the ground-glass appearance and fine mottling (stage I) progressed to a mixed picture of fine and coarse mottling, sometimes associated with persistence of the ground-glass appearance, but to a lesser degree (stage II) (Fig. 2) . As the disorder progressed and responded to treatment the groundglass appearance and fine mottling disappeared with the development of coarse mottling and the appearance of linear markings, usually perihilar (stage III) (Fig. 3) . In 6 of 8 patients who developed these changes, cardiomegaly was also present. The endstage chest x-ray was characterized by varying degrees of linear shadowing commonly associated with hypertranslucent areas (stage IV) (Fig. 4) . These hypertranslucent areas were particularly evident at the lung bases and when marked, resembled a honeycomb pattern. This feature was variable in its time of onset and was noted very early in one patient, within a few months of onset of symptoms. In the survivors this progression occurred over a 2-to 6-year period. Rapid progression from stage I to III in 3-4 months was occasionally noted.
Most frequently a generalized distribution of changes was present. In 3 patients, however, transient asymmetrical distribution was noted, with the right lung predominantly affected in 2. There was often concentration of these early changes around the hilar regions. In one patient early changes were present in the middle and lower zones. Later the upper zones became involved with relative sparing of the bases (Case 2). In another (Case 1) the upper zones were spared. The linear markings were seen radiating from the hilar region, where this feature was usually most notable. patient, and a small pneumothorax in 2, and extensive bilateral pneumothorax occurred in one patient (Case 10). Occasionally denser, poorly defined, frequently transient consolidated areas were seen. Areas of collapse were rare.
The late radiological features in those patients who died were variable in both grade and severity (Table 4 ). 4 of the 5 had mainly early features of moderate to severe degree. One patient (Case 2) the fine and coarse mottling, but these features sometimes reappeared within 7 days of reducing or stopping corticosteroid therapy. This cycle of radiological improvement and deterioration was seen on at least 4 occasions in one patient (Case 7). There was no clear correlation between the degree of intra-alveolar desquamation and the ground-glass, fine or coarse mottling appearance. Further, it was not possible to correlate the severity of mural thickening to the degree of linear markings on the x-ray.
Respiratory function tests. In 3 older children standard respiratory function tests requiring patient co-operation were made (Table 5) . In Case 5, aged 61, the studies were performed during the acute stage. There was gross reduction in lung volumes. Similar results were obtained in Case 7 when he was still symptomatic, 5 years after onset of the disease, when the chest x-ray showed stage II changes. On the other hand, Case 1, after a long illness, was asymptomatic when the tests were performed and his x-ray showed linear markings only. His lung volumes were high, but his Peak Flow Rate was low, suggesting the presence of obstructive airways disease.
In 4 children static lung compliance was measured as a preliminary investigation before open lung biopsy in the paralysed infant (Table 6 ). All the children were severely ill at the time of the test and it was therefore surprising to find that the static Table  7 in the manner of Scadding and Hinson (1967) 7) and slight in the other 3 (Fig. 8) .
There was histiocytic infiltration of the wall and an (Gordan and Sweet's methodfor reticulin. x 28.) polymorphs were seen within the alveoli (Fig. 9) . Intervening lung had minimal mural thickening and there was some overdistension of alveoli.
Steroid therapy. Analysis of effects of corticosteroid therapy is given in Table 8 . All but 2 children improved on corticosteroids. Case 5 received treatment with corticosteroids and tetracosactrin. Improvement coincided with discontinuation of hydrocortisone treatment which had been given to 'cover' the period of the lung biopsy. Case 10 had had treatment for only 3 days. The time taken before definite improvement was noted varied from as little as 5 days to 6 weeks. The effective daily dose of prednisolone was as little as 0 53 mg/kg in one patient and as much as 5 * 5 mg/kg in another. The dose on which clinical or radiological deterioration occurred was difficult to assess, since several changes of dose were often made in a short space of time. Deterioration occurred at a daily dose of 0-36 mg/kg of prednisolone in one patient and on 2 mg/kg in another, and was noted as early as 4 days after a reduction in corti- In 1956-57 there were a number of clinical reports of children with interstitial pulmonary fibrosis (Bradley, 1956; Aranson, 1956; Baar and Braid, 1957; Grant et al., 1956; Donohue, 1956; Feinerman and Mann (1959 Mann ( , 1965 . In all we found clinical details of 31 patients in the English and American literature ( Table 9 ), 19 developed respiratory symptoms within the first year of life. Of this latter group 3 were alive at the time of reporting, though in 2 the follow-up period was very short. The mean survival period of this group was approximately 4-7 months. Of the 12 cases who presented over one year of age, 5 were alive at the time of reporting and had survived for a period of from 6 months to 14 years. In this second group the mean survival time of those who had died naturally by the time of reporting was approximately 6 years.
There appear to be no cases of spontaneous remission of the condition in this group of 31 children; all the survivors were treated with corticosteroids. Cyanosis was present in 27 of the 31 patients reviewed. Pulmonary artery pressure was measured in 4 and was definitely raised in one. Electrocardiographic or post-mortem evidence of right ventricular hypertrophy was found in 14 children. Cardiac failure was recorded in 11 patients, all but 3 of whom were digitalized. Systemic blood pressure was normal in 7 patients in whom it was recorded. In only 2 cases was there good evidence for a superimposed bacterial infection. Spontaneous pneumothorax complicated 4 cases and in that reported by Aranson (1956) it appeared to contribute significantly to the patient's death.
Comparison between fibrosing alveolitis in children and adults. It is instructive to compare the clinical features of fibrosing alveolitis in children with those in adults. Large series of patients with interstitial pulmonary fibrosis in adults have been reported (Livingstone et al., 1964) and the literature reviewed (Rubin and Lubliner, 1957; Turner-Warwick, 1971/72 literature on fibrosing alveolitis in adults, fever has been a prominent feature of the condition in our series, and this did not always appear to indicate the presence of a superimposed bacterial respiratory infection. Many children with fibrosing alveolitis reported in the literature have had a pyrexia during the illness (Table 9 ). Essentially then, the clinical features in children and adults with fibrosing alveolitis are very similar but it is probably fair to say that in children it is usually a more acute illness and, if untreated, more predictably fatal.
Complications
Infection. The incidence of superimposed bacterial infection is low and in only 2 children reviewed (Baar and Braid, 1957; Donohue, 1956 ) did there seem good evidence of this. 3 of the 4 cases reported by Hamman and Rich (1944) had mucopurulent sputum and 1 of these had pulmonary tuberculosis. Bacterial infection in these cases may have been largely responsible for the more acute course of the condition. Turner-Warwick (1971/72) states that bronchial infection may occur, particularly in advanced cases in which obstruction is also present.
Bronchospasm. Two of the 4 children in our series who had evidence of recurrent episodes of bronchospasm also had convincing features of superimposed bacterial infection. In these 2 patients 1 had no family history of atopy (Case 7) and the father of the other (Case 6) was an asthmatic. Of the remaining 8 patients there was a definite family history of atopy in 1 (Case 4).
Haematological features. Persistent eosinophilia (noted in Case 1) has previously been reported in adult patients with fibrosing alveolitis and their relatives (Bonanni et al., 1965) . Eosinophilia in children with this condition has been noted by Johnston (1973 ), Buchta et al. (1970 , and Donohue (1956) . The persistent monocytosis in Case 2 was never explained, though the thrombocytopenia was thought to be secondary to the splenomegaly.
Gastrointestinal. The steatorrhoea and presumed disaccharide intolerance seen in Case 3 was never explained though a jejunal biopsy was not done. Coexisting diffuse pulmonary fibrosis and coeliac disease have been described (Hood and Mason, 1970) . Malabsorption might be explained on the basis of chronic portal venous congestion and hypoxia. In Case 7 there was no improvement of the diarrhoea on the disaccharide-free diet but this did occur concurrently with the improvement in the respiratory symptoms.
Aetiology. It seems possible that fibrosing alveolitis is the pathological expression of an abnormal response of the patient to a variety of stimuli. In some patients there is a strong family history. Donohue et al. (1959) reviewed the family history of children with pulmonary fibrosis and concluded that in those families with more than one member affected it was transmitted as a dominant gene with reduced penetrance. Hughes (1964) described 3 affected members of one family and reviewed evidence of the familial nature of interstitial pulmonary fibrosis. 2 of our patients were sibs. The inherited abnormality might lie in the immunological response. The immunopathological processes in fibrosing alveolitis are of interest also in view of the concurrence of a number of diseases of unknown aetiology, such as rheumatoid arthritis, chronic active hepatitis, ulcerative colitis, thyroid disease, and systemic lupus erythematosus, all frequently characterized by the presence of nonorgan-specific autoantibodies, which may also be present in fibrosing alveolitis occurring alone (Turner-Warwick, 1968) . Deposits of IgG, IgM, and the third complement (C3) have been shown in the alveolar walls of lung biopsies from cases of fibrosing alveolitis, mainly confined to regions without extensive fibrosis (Nagaya et al., 1973) . However, Poon et al. (1973) were unable to show any IgG, IgA, or IgM, C3, or fibrinogen in their case and concluded that this could be explained by the timing of the biopsy in relation to the course of the disease, or to variable aetiology. Evidence of involvement of the immunological system in the pathogenesis of fibrosing alveolitis has been reviewed by McCombs (1972) . Hobbs and Turner-Warwick (1967) found that one or more classes of immunoglobulins were increased above normal in 21 of 32 adult patients with fibrosing alveolitis. In the older children in this series the immunoglobulin levels also tended to be high, but in the infants they tended to be low or normal, suggesting an inadequate or inappropriate response. However, some of these values were obtained while the infants were on steroid therapy and are therefore difficult to interpret.
The insults which lead to widespread pulmonary fibrosis have been reviewed by Turner-Warwick (1974) . In none of our cases was there a definite history of exposure to drugs, organic or inorganic dusts likely to cause pulmonary fibrosis. Diffuse pulmonary fibrosis may occur in patients with pulmonary venous obstruction (Andrews, 1957) and it is interesting to note that this was seen in the infant reported by Diamond (1958) . Severe pul. monary infection resulting in widespread inflammatory exudates may progress to pulmonary fibrosis. Whitcomb et al. (1970) , in a well documented report on a 34-year-old male, describe generalized fibrosis after a Pneumocystis carinii infection. In the case reported by Baar and Braid (1957) the respiratory illness began with whooping cough at the age of 7 months. A similar occurrence in a 10-year-old boy has been reported by Zareba and Pyda (1966) . There is some evidence that viral infections might precipitate the initial illness (O'Shea and Yardley, 1970) . The clinical features suggested this possibility in Case 10 in this series.
Steroid therapy. Although all but 2 of our patients did improve on corticosteroids, it must be emphasized that it was sometimes difficult to be sure whether this could be attributed to concurrent treatment for a presumed respiratory infection, the corticosteroids, or perhaps a natural remission.
In the literature on adult interstitial pulmonary fibrosis an adequate dose of prednisolone is considered to be 30-40 mg/d. Scadding and Hinson (1967) found that all their patients who responded did so on a daily dose of 30 mg prednisolone. The symptoms in one patient reported in the series by Livingstone et al. (1964) were only controlled by prednisolone 40 mg daily. Similar and sometimes larger doses of corticosteroids have been reported for children (Rosenow, et al., 1970; Schneider et al., 1967) . However, in most of these reports it is difficult to assess whether such a high initial dose was really necessary, and this criticism applies equally to the 10 patients described here.
It is possible to get a clear idea of an 'adequate' dose of corticosteroids from that dose on which some patients relapsed. One patient clearly deteriorated on prednisolone 1 * 5 mg/kg per day (Case 6), and another (Case 9) on 2 mg/kg per day (Table 8) . It seems reasonable therefore that the starting dose of prednisolone should be at least 2 mg/kg per day. In view of the possibility of coexisting malabsorption, parenteral administration of corticosteroids ought to be considered if the patient fails to improve on oral therapy.
There is differing opinion in the literature as to the recommended duration of steroid therapy. An editorial in the British Medical Journal (1972) recommended a starting dose of prednisolone of 30-45 mg/d for 1 or 2 weeks, followed by a 'quite rapid' dose reduction to 10 mg/d. In the series of adult cases reported by Stack et al. (1972) prednisolone was usually given at a daily dose of 20-40 mg for a period of from 2-8 weeks, after which it was either stopped or reduced to a daily maintenance dose of 5-10 mg. In our series all of the children who improved on corticosteroid therapy did so within 6 weeks of starting treatment, but in 3 of these improvement was not noted until the third to sixth week of treatment. In the case of the 13-year-old boy reported by Midwinter et al. (1966) , who was initially treated with prednisolone 10 mg twice daily for 3 months, improvement was noted only after 2 months of therapy. Thus a fair trial of steroid therapy in children would be of at least 4 weeks' duration and preferably 8 weeks. Rosenow et al. (1970) emphasize that the duration of treatment has to be individualized according to the response obtained, but for desquamative interstitial pneumonia recommended at least a 1-year and preferably a 2-year course of steroid therapy. Our results support their advice that withdrawal of steroids should be cautious and protracted. Livingstone et al. (1964) feel that treatment with steroids is not indicated for those asymptomatic patients with the chronic form of the disease, or for those in whom the symptoms were static or only slowly progressive. None of our patients could be included in this category. They also make the point that though the presence of pulmonary fibrosis on lung biopsy might be considered unfavourable, it cannot be assumed that more acute lesions are not present and therefore treatment with steroids should not be withheld on this score. Correlation of biopsy histology and steroid responsiveness in our series certainly seems to bear out this point.
In lung biopsies from their patients, Scadding and Hinson (1967) found an inverse relation between the amounts of cellular desquamation into the alveoli and the degree of alveolar wall thickening. They also showed a relation between slight thickening of the wall and the uniformity of changes within the biopsy specimen, though drawing attention to the small size of the sample compared with lung volume. We were unable to find such good correlation between these parameters, though the presence of lymphoid follicles was associated with prominent cellular desquamation. This may be due to poor sampling or indicate a different course of the disease in children. They also found that steroid therapy suppressed symptoms and signs in a few of the patients whose biopsy showed only slight alveolar wall thickening and many intra-alveolar mononuclear cells, but in none of those with much thickened alveolar walls. In addition, they found no relationship between histology at time of biopsy and total duration of the disease from onset to death. There is no such correlation in this series. 
